METRELEPTIN for Product used for unknown indication: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 97 adverse event reports in the FDA FAERS database where METRELEPTIN was used for Product used for unknown indication.
Most Reported Side Effects for METRELEPTIN
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Therapy cessation | 94 | 8.3% | 7 | 42 |
| Product dose omission issue | 88 | 7.8% | 2 | 22 |
| Weight decreased | 88 | 7.8% | 2 | 20 |
| Blood glucose increased | 77 | 6.8% | 0 | 21 |
| Drug ineffective | 69 | 6.1% | 3 | 15 |
| Therapy interrupted | 65 | 5.7% | 2 | 35 |
| Nausea | 57 | 5.0% | 2 | 22 |
| Off label use | 51 | 4.5% | 8 | 23 |
| Blood triglycerides increased | 49 | 4.3% | 0 | 19 |
| Treatment noncompliance | 49 | 4.3% | 4 | 24 |
| Weight increased | 45 | 4.0% | 0 | 9 |
| Decreased appetite | 43 | 3.8% | 2 | 12 |
| Injection site pain | 42 | 3.7% | 1 | 4 |
| Maternal exposure during pregnancy | 41 | 3.6% | 0 | 1 |
| Hypoglycaemia | 40 | 3.5% | 2 | 12 |
Other Indications for METRELEPTIN
Lipodystrophy acquired (477)
Congenital generalised lipodystrophy (394)
Familial partial lipodystrophy (58)
Partial lipodystrophy (51)
Acquired generalised lipodystrophy (36)
Lipoatrophy (16)
Non-alcoholic steatohepatitis (9)
Diabetes mellitus (6)
Hypertriglyceridaemia (6)
Other Drugs Used for Product used for unknown indication
OXYCODONE (129,391)
ADAPALENE (91,681)
APIXABAN (88,417)
ETANERCEPT (71,866)
SACUBITRIL\VALSARTAN (69,693)
ACETAMINOPHEN (68,427)
AVOBENZONE\OCTISALATE\OCTOCRYLENE (65,206)
ADALIMUMAB (63,549)
EVOLOCUMAB (60,696)
MORPHINE (59,440)